INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "RECEPTOR-MEDIATED ENDOCYTOSIS FOR TARGETED INTERNALIZATION AND DEGRADATION OF IMMUNE-RELATED MEMBRANE PROTEINS"

GENEVA, Sept. 22 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215) filed a patent application (PCT/US2025/020271) for "RECEPTOR-MEDIATED ENDOCYTOSIS FOR TARGETED INTERNALIZATION AND DEGRADATION OF IMMUNE-RELATED MEMBRANE PROTEINS" on Mar 17, 2025. With publication no. WO/2025/194170, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHOU, Xin (450 Brookline AvenueBoston, Massachusetts 02215)

Abstract: Disclosed are fusion proteins (and homodimers and heterodimers thereof). Fusion pro...